4.3 Article

Mesenchymal Stem Cell Extracellular Vesicles as Adjuvant to Bone Marrow Stimulation in Chondral Defect Repair in a Minipig Model

Journal

CARTILAGE
Volume 13, Issue 2_SUPPL, Pages 254S-266S

Publisher

SAGE PUBLICATIONS INC
DOI: 10.1177/19476035211029707

Keywords

articular cartilage; cartilage repair; knee; bone marrow stimulation; mesenchymal stem cells

Categories

Funding

  1. Danish Rheumatism Association
  2. Direktor Emil C. Hertz og Hustru Inger Hertz' Fond

Ask authors/readers for more resources

The study found that intraarticular injections of mesenchymal stem cell-extracellular vesicles (MSC-EVs) in conjunction with bone marrow stimulation (BMS) could enhance bone formation in the cartilage defect area, but compromised the repair of hyaline cartilage.
Objective This study evaluated the effects of mesenchymal stem cell-extracellular vesicles (MSC-EVs) on chondrocyte proliferation in vitro and on cartilage repair in vivo following bone marrow stimulation (BMS) of focal chondral defects of the knee. Methods Six adult Gottingen minipigs received 2 chondral defects in each knee. The pigs were randomized to treatment with either BMS combined with MSC-EVs or BMS combined with phosphate-buffered saline (PBS). Intraarticular injections MSC-EVs or PBS were performed immediately after closure of the surgical incisions, and at 2 and 4 weeks postoperatively. Repair was evaluated after 6 months with gross examination, histology, histomorphometry, immunohistochemistry, and micro-computed tomography (mu CT) analysis of the trabecular bone beneath the defect. Results Defects treated with MSC-EVs had more bone in the cartilage defect area than the PBS-treated defects (7.9% vs. 1.5%, P = 0.02). Less than 1% of the repair tissue in both groups was hyaline cartilage. International Cartilage and Joint Preservation Society II histological scoring showed that defects treated with MSC-EVs scored lower on matrix staining (20.8 vs. 50.0, P = 0.03), cell morphology (35.4 vs. 53.8, P = 0.04), and overall assessment (30.8 vs. 52.9, P = 0.03). Consistently, defects treated with MSC-EVs had lower collagen II and higher collagen I areal deposition. Defects treated with MSC-EVs had subchondral bone with significantly higher tissue mineral densities than PBS-treated defects (860 mg HA/cm(3) vs. 838 mg HA/cm(3), P = 0.02). Conclusion Intraarticular injections of MSC-EVs in conjunction with BMS led to osseous ingrowth that impaired optimal cartilage repair, while enhancing subchondral bone healing.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available